Events

Enalare Therapeutics to Present at BIO-Europe Spring Conference
Enalare Therapeutics to Participate in Biotech Showcase

Press Releases

Enalare Therapeutics Announces Closing of Successful Seed Funding Round
Enalare Therapeutics Appoints Mark Coleman M.D. to Its Board of Directors
Enalare Therapeutics Completes Formation of Its Scientific Advisory Board
Enalare Therapeutics Appoints 3 New Members to Its Board of Directors
Enalare Therapeutics Appoints Daniel Motto as Chief Business Officer
Enalare Therapeutics Appoints Herm Cukier as Executive Chairman, President, and CEO

Corporate

Full Corporate Presentation
Company Introduction
Vortsman

Dr. Eugene Vortsman, Northwell Health System
Practicing Emergency Medicine Specialist

Gan

Dr. TJ Gan – Stony Brook University
Professor of and Chair, Department of Anesthesiology

ENA-001 Publications

(formerly GAL-021)

Two Studies on Reversal of Opioid-induced Respiratory Depression by BK-channel Blocker GAL021 in Human Volunteers
The Latest Pharmacologic Ventilator
Respiratory stimulant drugs in the post-operative setting
Opioid-induced respiratory depression: reversal by non-opioid drugs
GAL-021, a new intravenous BKCa-channel blocker, is well tolerated and stimulates ventilation in healthy volunteers

Additional Resources

Commentary: New Complications Make Treatment of “Opioid” Overdose Challenging
Commentary: “Ockham’s Razor” Doesn’t Apply to “Opioid” Overdose Death
Prediction of Opioid-Induced Respiratory Depression on Inpatient Wards Using Continuous Capnography and Oximetry: An International Prospective, Observational Trial
The Polysubstance Overdose-Death Crisis
The CDC issued a Health Alert Network advisory to medical and public health professionals and others Thursday, saying drug overdose deaths have soared to the highest number ever recorded in a 12-month period.